Aeolus Pharmaceuticals AOLS Stock
Aeolus Pharmaceuticals Price Chart
Aeolus Pharmaceuticals AOLS Financial and Trading Overview
| Aeolus Pharmaceuticals stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.0002 USD |
| Volume | 15.38K USD |
| Avg. Volume | 2.26K USD |
| Market Cap | 167.29K USD |
| Beta (5Y Monthly) | -4.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AOLS Valuation Measures
| Enterprise Value | -387791 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.21698314 |
| Price/Book (mrq) | 0.099999994 |
| Enterprise Value/Revenue | -0.503 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Aeolus Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -4.35 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0002 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
AOLS Share Statistics
| Avg. Volume (3 month) | 2.26K USD |
| Avg. Daily Volume (10-Days) | 1.54K USD |
| Shares Outstanding | 152.09M |
| Float | 47.04M |
| Short Ratio | 0 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 0 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2016 |
| Most Recent Quarter (mrq) | June 30, 2017 |
| Next Fiscal Year End | September 30, 2017 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -530.99% |
| Gross Margin | -223.21% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -90.30% |
| Return on Equity (ttm) | -186.42% |
Income Statement
| Revenue (ttm) | 771K USD |
| Revenue Per Share (ttm) | 0.005 USD |
| Quarterly Revenue Growth (yoy) | -98.00000000000000000000000000000000% |
| Gross Profit (ttm) | -805000 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -4094000 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 403K USD |
| Total Cash Per Share (mrq) | 0.003 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.298 |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3353000 USD |
| Levered Free Cash Flow (ttm) | -1805750 USD |
Profile of Aeolus Pharmaceuticals
| Country | United States |
| State | CA |
| City | Mission Viejo |
| Address | 26361 Crown Valley Parkway |
| ZIP | 92691 |
| Phone | 949-481-9825 |
| Website | https://www.aeoluspharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.
Q&A For Aeolus Pharmaceuticals Stock
What is a current AOLS stock price?
Aeolus Pharmaceuticals AOLS stock price today per share is 0.0001 USD.
How to purchase Aeolus Pharmaceuticals stock?
You can buy AOLS shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aeolus Pharmaceuticals?
The stock symbol or ticker of Aeolus Pharmaceuticals is AOLS.
Which industry does the Aeolus Pharmaceuticals company belong to?
The Aeolus Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Aeolus Pharmaceuticals have in circulation?
The max supply of Aeolus Pharmaceuticals shares is 1.67B.
What is Aeolus Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Aeolus Pharmaceuticals PE Ratio is now.
What was Aeolus Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Aeolus Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Aeolus Pharmaceuticals company belong to?
The Aeolus Pharmaceuticals sector is Healthcare.